January 08, 2025 04:29 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Sheesh Mahal row: AAP leaders who were denied entry into CM's residence turn towards PM's house | Anna University sexual assault accused is a DMK supporter, not member: MK Stalin | Ajit Doval, Raja Dato discuss bilateral cooperation during India-Malaysia Security Dialogue | US President-elect Donald Trump threatens to use economic force to make Canada 51st US State, Justin Trudeau retorts sharply | Elon Musk raises concern on 'world population decline' including that of India, China | Indian-origin Anita Ananda might replace Justin Trudeau as Canadian PM | 'I won't bite': Kamala Harris tells Senator's husband as he refuses to shake hands with her | Centre announces memorial for Pranab Mukherjee, his daughter thanks PM Modi for 'gracious gesture' | Delhi assembly elections on Feb 5, results on Feb 8 | Allu Arjun visits boy injured during Pushpa 2 stampede in Hyderabad
Pfizer says its antiviral pill 89 pc effective in preventing severe Covid

Pfizer says its antiviral pill 89 pc effective in preventing severe Covid

Nov 06, 2021, at 06:12 am

Pfizer has stopped the clinical trial for experimental antiviral pill for COVID-19 before the stipulated period after the drug was shown to reduce by 89 percent the chances of hospitalization or death for adults at risk of developing severe symptoms, the company said.